Page last updated: 2024-11-03

primaquine and Acute Promyelocytic Leukemia

primaquine has been researched along with Acute Promyelocytic Leukemia in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ma, L1
Chen, L1
Li, H1
Ge, L1
Wang, S1
Zhang, Z1
Huang, H1
Shi, L1
Li, T1
Gu, H1
Lyu, J1
He, L1

Other Studies

1 other study available for primaquine and Acute Promyelocytic Leukemia

ArticleYear
Primaquine phosphate induces the apoptosis of ATRA-resistant acute promyelocytic leukemia cells by inhibition of the NF-κB pathway.
    Journal of leukocyte biology, 2020, Volume: 107, Issue:4

    Topics: Adult; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neo

2020